 BNP Paribas Arbitrage SA boosted its stake in Heron Therapeutics Inc NASDAQ:HRTX by 782.5 in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission SEC. The fund owned 104,597 shares of the biotechnology companys stock after acquiring an additional 92,744 shares during the period. BNP Paribas ... 